Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Genasys (GNSS) over the last 16 years, with Q3 2025 value amounting to $8.0 million.

  • Genasys' Cash & Equivalents rose 6115.27% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 6115.27%. This contributed to the annual value of $8.0 million for FY2025, which is 6115.27% up from last year.
  • Genasys' Cash & Equivalents amounted to $8.0 million in Q3 2025, which was up 6115.27% from $5.3 million recorded in Q2 2025.
  • Genasys' 5-year Cash & Equivalents high stood at $18.5 million for Q1 2021, and its period low was $3.0 million during Q2 2023.
  • Its 5-year average for Cash & Equivalents is $8.7 million, with a median of $8.5 million in 2024.
  • In the last 5 years, Genasys' Cash & Equivalents tumbled by 7465.67% in 2023 and then surged by 19188.83% in 2024.
  • Quarter analysis of 5 years shows Genasys' Cash & Equivalents stood at $10.1 million in 2021, then decreased by 25.38% to $7.6 million in 2022, then crashed by 36.8% to $4.8 million in 2023, then soared by 77.18% to $8.5 million in 2024, then fell by 5.9% to $8.0 million in 2025.
  • Its Cash & Equivalents was $8.0 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.7 million in Q1 2025.